PPPablo Noel Perez-Guzman

Pablo Noel Perez-Guzman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pablo Noel Perez-Guzman has a total of 186 co-authors. Here are the top co-authors by number of shared publications:

  • Neil Morris Ferguson

    MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK

    7 shared publications
  • Anne Cori

    Imperial College London, Medical Research Council Centre for Global Infectious Disease Analysis, and Abdul Latif Jameel Institute for Disease and Emergency Analytics, School of Public Health, London, UK

    5 shared publications
  • Graham Cooke

    MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, UK

    5 shared publications
  • Katharina Hauck

    MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, UK

    4 shared publications
  • Katharina Hauck

    MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK

    4 shared publications
  • Marc Baguelin

    MRC Centre for Global Infectious Disease Analysis, Abdul Latif Jameel Institute for Disease and Emergency Analytics (J-IDEA), School of Public Health, Imperial College London

    4 shared publications

Latest Publications

  • Early epidemiological and spatial assessment of the Bundibugyo virus outbreak 2026

    by Dav M. Ebengo, Pierre Akilimali, Tania Bishola Tshitenge, Ciara Judge, Bernardo Gutierrez, Ellie Bourgikos, Olivier le Polain de Waroux, Eddy Kinganda-Lusamaki, Tony Wawina-Bokalanga, Adrienne Aziza-Amuri, et al.

    A Bundibugyo virus outbreak was first reported on May 15th, 2026 in Ituri province, Democratic Republic of the Congo, with multiple cases reported across health zones during the early phase of the outbreak and suggestions of circulation weeks prior to detection. We pair highly resolved case and testing records with human mobility data to investigate the early outbreak dynamics of Bundibugyo virus disease (BVD). We show that human movement was a principle driver of early spatial expansion between May 10th and June 1st when the number of health zones and health areas reporting positive cases increased by 12 and 49, respectively. The early doubling time was estimated at ~10 days. Our work shows the rapid spatial expansion and growth of BVD with implications for intervention strategies.


  • Open Access

    Socioeconomic and temporal heterogeneity in SARS-CoV-2 exposure and disease in England from May 2020 to February 2023

    by Christian Morgenstern, Thomas Rawson, Wes Hinsley, Pablo N. Perez Guzman, Samir Bhatt, Neil M. Ferguson

    The impact of COVID-19 varied significantly by deprivation, ethnicity, and policy measures. We analyzed individual-level data on 12,310,485 first SARS-CoV-2 Pillar 2–PCR-confirmed infections, 439,083 hospitalizations, 107,823 deaths, and vaccination records in England from May 2020 to February 2022. Poisson regression models adjusted for demographic and temporal factors showed higher incidence rate ratios (IRRs) for severe outcomes in the most deprived areas compared to the least. We note higher IRRs for severe outcomes for all non-white relative to white ethnicities. The magnitude of IRRs for both deprivation and ethnicities declined from the wild-type to the omicron periods for severe outcomes. For infections, we observed IRRs above one for non-white ethnicities during the wild-type and alpha periods. Vaccination significantly reduced risks across all groups. For severe outcomes, preexisting health inequalities led to large and persistent disparities. For infections, measures must be structured with ethnicity and deprivation in mind early in a pandemic.


  • Open Access

    Pandemic burden in low-income settings and impact of limited and delayed interventions: A granular modelling analysis of COVID-19 in Kabwe, Zambia

    by Pablo N. Perez-Guzman, Stephen Longa Chanda, Albertus Schaap, Kwame Shanaube, Marc Baguelin, Sarah T. Nyangu, Muzala Kapina Kanyanga, Patrick Walker, Helen Ayles, Roma Chilengi, et al.


  • Open Access

    Author Correction: Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England

    by Pablo N Perez-Guzman, Edward Knock, Natsuko Imai, Thomas Rawson, Yasin Elmaci, Joana Alcada, Lilith K Whittles, Divya Thekke Kanapram, Raphael Sonabend, Katy A M Gaythorpe, et al.


  • Open Access

    Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England

    by Pablo N. Perez-Guzman, Edward Knock, Natsuko Imai, Thomas Rawson, Yasin Elmaci, Joana Alcada, Lilith K. Whittles, Divya Thekke Kanapram, Raphael Sonabend, Katy A. M. Gaythorpe, et al.

    As the SARS-CoV-2 pandemic progressed, distinct variants emerged and dominated in England. These variants, Wildtype, Alpha, Delta, and Omicron were characterized by variations in transmissibility and severity. We used a robust mathematical model and Bayesian inference framework to analyse epidemiological surveillance data from England. We quantified the impact of non-pharmaceutical interventions (NPIs), therapeutics, and vaccination on virus transmission and severity. Each successive variant had a higher intrinsic transmissibility. Omicron (BA.1) had the highest basic reproduction number at 8.4 (95% credible interval (CrI) 7.8-9.1). Varying levels of NPIs were crucial in controlling virus transmission until population immunity accumulated. Immune escape properties of Omicron decreased effective levels of immunity in the population by a third. Furthermore, in contrast to previous studies, we found Alpha had the highest basic infection fatality ratio (3.0%, 95% CrI 2.8-3.2), followed by Delta (2.1%, 95% CrI 1.9–2.4), Wildtype (1.2%, 95% CrI 1.1–1.2), and Omicron (0.7%, 95% CrI 0.6-0.8). Our findings highlight the importance of continued surveillance. Long-term strategies for monitoring and maintaining effective immunity against SARS-CoV-2 are critical to inform the role of NPIs to effectively manage future variants with potentially higher intrinsic transmissibility and severe outcomes.


  • Open Access

    Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England

    by Pablo N Perez-Guzman, Edward Knock, Natsuko Imai, Thomas Rawson, Yasin Elmaci, Joana Alcada, Lilith K Whittles, Divya Thekke Kanapram, Raphael Sonabend, Katy Am Gaythorpe, et al.

    As the SARS-CoV-2 pandemic progressed, distinct variants emerged and dominated in England. These variants, Wildtype, Alpha, Delta, and Omicron were characterized by variations in transmissibility and severity. We used a robust mathematical model and Bayesian inference framework to analyse epidemiological surveillance data from England. We quantified the impact of non-pharmaceutical interventions (NPIs), therapeutics, and vaccination on virus transmission and severity. Each successive variant had a higher intrinsic transmissibility. Omicron (BA.1) had the highest basic reproduction number at 8.3 (95% credible interval (CrI) 7.7-8.8). Varying levels of NPIs were crucial in controlling virus transmission until population immunity accumulated. Immune escape properties of Omicron decreased effective levels of immunity in the population by a third. Furthermore, in contrast to previous studies, we found Alpha had the highest basic infection fatality ratio (2.9%, 95% CrI 2.7-3.2), followed by Delta (2.2%, 95% CrI 2.0-2.4), Wildtype (1.2%, 95% CrI 1.1-1.2), and Omicron (0.7%, 95% CrI 0.6-0.8). Our findings highlight the importance of continued surveillance. Long-term strategies for monitoring and maintaining effective immunity against SARS-CoV-2 are critical to inform the role of NPIs to effectively manage future variants with potentially higher intrinsic transmissibility and severe outcomes.


  • Open Access

    The impact of the COVID-19 pandemic on patterns of attendance at emergency departments in two large London hospitals: an observational study

    by Michaela A. C. Vollmer, Sreejith Radhakrishnan, Mara D. Kont, Seth Flaxman, Samir Bhatt, Ceire Costelloe, Kate Honeyford, Paul Aylin, Graham Cooke, Julian Redhead, et al.

    Background: Hospitals in England have undergone considerable change to address the surge in demand imposed by the COVID-19 pandemic. The impact of this on emergency department (ED) attendances is unknown, especially for non-COVID-19 related emergencies. Methods: This analysis is an observational study of ED attendances at the Imperial College Healthcare NHS Trust (ICHNT). We calibrated auto-regressive integrated moving average time-series models of ED attendances using historic (2015–2019) data. Forecasted trends were compared to present year ICHNT data for the period between March 12, 2020 (when England implemented the first COVID-19 public health measure) and May 31, 2020. We compared ICHTN trends with publicly available regional and national data. Lastly, we compared hospital admissions made via the ED and in-hospital mortality at ICHNT during the present year to the historic 5-year average. Results: ED attendances at ICHNT decreased by 35% during the period after the first lockdown was imposed on March 12, 2020 and before May 31, 2020, reflecting broader trends seen for ED attendances across all England regions, which fell by approximately 50% for the same time frame. For ICHNT, the decrease in attendances was mainly amongst those aged < 65 years and those arriving by their own means (e.g. personal or public transport) and not correlated with any of the spatial dependencies analysed such as increasing distance from postcode of residence to the hospital. Emergency admissions of patients without COVID-19 after March 12, 2020 fell by 48%; we did not observe a significant change to the crude mortality risk in patients without COVID-19 (RR 1.13, 95%CI 0.94–1.37, p = 0.19). Conclusions: Our study findings reflect broader trends seen across England and give an indication how emergency healthcare seeking has drastically changed. At ICHNT, we find that a larger proportion arrived by ambulance and that hospitalisation outcomes of patients without COVID-19 did not differ from previous years. The extent to which these findings relate to ED avoidance behaviours compared to having sought alternative emergency health services outside of hospital remains unknown. National analyses and strategies to streamline emergency services in England going forward are urgently needed.


  • Open Access

    Optimal national prioritization policies for hospital care during the SARS-CoV-2 pandemic

    by Josh C. D’aEth, Shubhechyya Ghosal, Fiona Grimm, David Haw, Esma Koca, Krystal Lau, Stefano Moret, Dheeya Rizmie, Sarah R. Deeny, Pablo N. Perez-Guzman, et al.

    In response to unprecedented surges in the demand for hospital care during the SARS-CoV-2 pandemic, health systems have prioritized patients with COVID-19 to life-saving hospital care to the detriment of other patients. In contrast to these ad hoc policies, we develop a linear programming framework to optimally schedule elective procedures and allocate hospital beds among all planned and emergency patients to minimize years of life lost. Leveraging a large dataset of administrative patient medical records, we apply our framework to the National Health Service in England and show that an extra 50,750–5,891,608 years of life can be gained compared with prioritization policies that reflect those implemented during the pandemic. Notable health gains are observed for neoplasms, diseases of the digestive system, and injuries and poisoning. Our open-source framework provides a computationally efficient approximation of a large-scale discrete optimization problem that can be applied globally to support national-level care prioritization policies.


  • Open Access

    Key epidemiological drivers and impact of interventions in the 2020 SARS-CoV-2 epidemic in England

    by Edward S. Knock, Lilith K. Whittles, John A. Lees, Pablo N. Perez-Guzman, Robert Verity, Richard G. FitzJohn, Katy A. M. Gaythorpe, Natsuko Imai, Wes Hinsley, Lucy C. Okell, et al.

    We fitted a model of SARS-CoV-2 transmission in care homes and the community to regional surveillance data for England. Compared with other approaches, our model provides a synthesis of multiple surveillance data streams into a single coherent modelling framework allowing transmission and severity to be disentangled from features of the surveillance system. Of the control measures implemented, only national lockdown brought the reproduction number (Rteff) below 1 consistently; if introduced one week earlier it could have reduced deaths in the first wave from an estimated 48,600 to 25,600 (95% credible interval [95%CrI]: 15,900–38,400). The infection fatality ratio decreased from 1.00% (95%CrI: 0.85%–1.21%) to 0.79% (95%CrI: 0.63%–0.99%), suggesting improved clinical care. The infection fatality ratio was higher in the elderly residing in care homes (23.3%, 95%CrI: 14.7%–35.2%) than those residing in the community (7.9%, 95%CrI: 5.9%–10.3%). On 2nd December 2020 England was still far from herd immunity, with regional cumulative infection incidence between 7.6% (95%CrI: 5.4%–10.2%) and 22.3% (95%CrI: 19.4%–25.4%) of the population. Therefore, any vaccination campaign will need to achieve high coverage and a high degree of protection in vaccinated individuals to allow non-pharmaceutical interventions to be lifted without a resurgence of transmission.


  • Open Access

    Characteristics and outcomes of clinically diagnosed RT-PCR swab negative COVID-19: a retrospective cohort study

    by Paul Middleton, Pablo N. Perez-Guzman, Alexandra Cheng, Naveenta Kumar, Mara D. Kont, Anna Daunt, Sujit Mukherjee, Graham Cooke, Timothy B. Hallett, Katharina Hauck, et al.

    Patients with strong clinical features of COVID-19 with negative real time polymerase chain reaction (RT-PCR) SARS-CoV-2 testing are not currently included in official statistics. The scale, characteristics and clinical relevance of this group are not well described. We performed a retrospective cohort study in two large London hospitals to characterize the demographic, clinical, and hospitalization outcome characteristics of swab-negative clinical COVID-19 patients. We found 1 in 5 patients with a negative swab and clinical suspicion of COVID-19 received a clinical diagnosis of COVID-19 within clinical documentation, discharge summary or death certificate. We compared this group to a similar swab positive cohort and found similar demographic composition, symptomology and laboratory findings. Swab-negative clinical COVID-19 patients had better outcomes, with shorter length of hospital stay, reduced need for > 60% supplementary oxygen and reduced mortality. Patients with strong clinical features of COVID-19 that are swab-negative are a common clinical challenge. Health systems must recognize and plan for the management of swab-negative patients in their COVID-19 clinical management, infection control policies and epidemiological assessments.